Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.53 |
| ▸ | LTA4H | P09960 | 4/20 | 0.48 |
| ▸ | PARP10 | Q53GL7 | 3/20 | 0.48 |
| ▸ | LAP3 | P28838 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8935262 | 0.85 | ACACB (0.54) | LTA4HDPP4 | |
| SCHEMBL8935407 | 0.82 | PARP10 (0.61) | MAOBLTA4HPARP10LAP3 | |
| SCHEMBL27571002 | 0.81 | MAOB (0.58) | MAOBLTA4HLAP3PPARAPPARG | |
| SCHEMBL6368851 | 0.81 | MAOB (0.58) | MAOBLTA4HLAP3PPARAPPARG | |
| SCHEMBL7395944 | 0.77 | MAOB (0.59) | MAOB | |
| SCHEMBL8935239 | 0.77 | MAOB (0.63) | MAOBPARP10 | |
| SCHEMBL289033 | 0.76 | LTA4H (0.67) | MAOBLTA4HPARP10LAP3PPARA | |
| SCHEMBL5888154 | 0.76 | LTA4H (0.67) | MAOBLTA4HPARP10LAP3PPARA | |
| SCHEMBL8935436 | 0.75 | SCN3A (0.61) | MAOBPARP10 | |
| SCHEMBL8935281 | 0.75 | MAOB (0.56) | MAOBLTA4HLAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5502079-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | FARMITALIA CARLO ERBA S.R.L. (IT) | 1996-03-26 | — | — | US | disclosed |